FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder

FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More »

South Africa returns to stricter lockdown, virus ‘surging’

Loading the player… South African President Cyril Ramaphosa announced Sunday that his country will return to stricter lockdown measures in the face of a sharp rise in COVID-19 cases that indicate the virus is “surging again” in Africa’s worst-affected nation. Positive cases in South Africa in the past seven days were 31% higher than the… Read More »